Managed Care and Biosimilars
from GHAPPcast
In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars. The learning objectives for this episode are to: Discuss managed care implications for biosimilars reaching the market Identify the benefits of biosimilars in managed care Formulate strategies managed care professionals can employ to establish clinical pathways and increase biosimilar uptake in practice Please take our evaluation regarding this podcast here: https://www.ghapp.org/biosimilars-podcast-eval
Embed this episode
What this episode covers
In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars.The learning objectives for this episode are to:Discuss managed care implications for biosimilars reaching the marketIdentify the benefits of biosimilars in managed careFormulate strategies managed care professionals can employ to establish clinical pathways and increase biosimilar uptake in practicePlease t...
No transcript yet.